276 related articles for article (PubMed ID: 26921521)
1. Genetic engineering of platelets to neutralize circulating tumor cells.
Li J; Sharkey CC; Wun B; Liesveld JL; King MR
J Control Release; 2016 Apr; 228():38-47. PubMed ID: 26921521
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.
Li J; Ai Y; Wang L; Bu P; Sharkey CC; Wu Q; Wun B; Roy S; Shen X; King MR
Biomaterials; 2016 Jan; 76():52-65. PubMed ID: 26519648
[TBL] [Abstract][Full Text] [Related]
3. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules.
Liu Y; Zhang Y; Ding Y; Zhuang R
Crit Rev Oncol Hematol; 2021 Nov; 167():103502. PubMed ID: 34662726
[TBL] [Abstract][Full Text] [Related]
4. Metastasis: new functional implications of platelets and megakaryocytes.
Leblanc R; Peyruchaud O
Blood; 2016 Jul; 128(1):24-31. PubMed ID: 27154188
[TBL] [Abstract][Full Text] [Related]
5. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
[TBL] [Abstract][Full Text] [Related]
6. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
7. TRAIL inhibits platelet-induced colorectal cancer cell invasion.
Wu LS; Wang XW; He W; Ma XT; Wang HY; Han M; Li BH
J Int Med Res; 2019 Feb; 47(2):962-972. PubMed ID: 30621488
[TBL] [Abstract][Full Text] [Related]
8. TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients.
Ortiz-Otero N; Marshall JR; Glenn A; Matloubieh J; Joseph J; Sahasrabudhe DM; Messing EM; King MR
BMC Cancer; 2021 Aug; 21(1):898. PubMed ID: 34362331
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
[TBL] [Abstract][Full Text] [Related]
10. Contribution of platelets to tumour metastasis.
Gay LJ; Felding-Habermann B
Nat Rev Cancer; 2011 Feb; 11(2):123-34. PubMed ID: 21258396
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.
Liang H; Yang C; Zhang B; Wang H; Liu H; Zhao Z; Zhang Z; Wen X; Lai X
Med Oncol; 2015 May; 32(5):151. PubMed ID: 25832864
[TBL] [Abstract][Full Text] [Related]
12. Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial.
Brady L; Hayes B; Sheill G; Baird AM; Guinan E; Stanfill B; Vlajnic T; Casey O; Murphy V; Greene J; Allott EH; Hussey J; Cahill F; Van Hemelrijck M; Peat N; Mucci L; Cunningham M; Grogan L; Lynch T; Manecksha RP; McCaffrey J; O'Donnell D; Sheils O; O'Leary J; Rudman S; McDermott R; Finn S
PLoS One; 2020; 15(12):e0243928. PubMed ID: 33338056
[TBL] [Abstract][Full Text] [Related]
13. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
[No Abstract] [Full Text] [Related]
14. Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
Ward MP; E Kane L; A Norris L; Mohamed BM; Kelly T; Bates M; Clarke A; Brady N; Martin CM; Brooks RD; Brooks DA; Selemidis S; Hanniffy S; Dixon EP; A O'Toole S; J O'Leary J
Mol Cancer; 2021 Mar; 20(1):59. PubMed ID: 33789677
[TBL] [Abstract][Full Text] [Related]
15. Platelet TLR4-ERK5 Axis Facilitates NET-Mediated Capturing of Circulating Tumor Cells and Distant Metastasis after Surgical Stress.
Ren J; He J; Zhang H; Xia Y; Hu Z; Loughran P; Billiar T; Huang H; Tsung A
Cancer Res; 2021 May; 81(9):2373-2385. PubMed ID: 33687949
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells promote the metastatic colonization of disseminated carcinoma cells by inducing systemic inflammation.
Li YC; Zou JM; Luo C; Shu Y; Luo J; Qin J; Wang Y; Li D; Wang SS; Chi G; Guo F; Zhang GM; Feng ZH
Oncotarget; 2017 Apr; 8(17):28418-28430. PubMed ID: 28415700
[TBL] [Abstract][Full Text] [Related]
17. Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells.
Ortiz-Otero N; Marshall JR; Lash BW; King MR
Nanoscale Adv; 2020 Sep; 2(9):3942-3953. PubMed ID: 36132797
[TBL] [Abstract][Full Text] [Related]
18. A conduit to metastasis: circulating tumor cell biology.
Micalizzi DS; Maheswaran S; Haber DA
Genes Dev; 2017 Sep; 31(18):1827-1840. PubMed ID: 29051388
[TBL] [Abstract][Full Text] [Related]
19. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
Chen JF; Ho H; Lichterman J; Lu YT; Zhang Y; Garcia MA; Chen SF; Liang AJ; Hodara E; Zhau HE; Hou S; Ahmed RS; Luthringer DJ; Huang J; Li KC; Chung LW; Ke Z; Tseng HR; Posadas EM
Cancer; 2015 Sep; 121(18):3240-51. PubMed ID: 25975562
[TBL] [Abstract][Full Text] [Related]
20. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
